EUVIMEDObjevte EUVIMED
CrossrefInformační karta

Effects of vaginal microbiota transfer on social–emotional and neurodevelopment in cesarean‐born infants: 12‐month follow‐up of a pilot randomized clinical trial

Chuhui Zhou, Lepeng Zhou, Hao Liu, Linghong Tang, Meng Li, Huiling Shang, Daniel Krewski, Shi Wu Wen, Yan He, Ri‐hua Xie

Acta Obstetricia et Gynecologica Scandinavica · 2026-06 · 105 (6) · 1064-1074

DOI: 10.1111/aogs.70218 ↗
AbstraktBibliografické údaje

Abstrakt

Abstract Introduction To evaluate the effects of vaginal microbiota transfer (VMT) on social–emotional development and to assess whether neurodevelopmental benefits observed at 6 months persist at 12 months in cesarean‐born infants. Material and Methods This 12‐month follow‐up study extended a prior randomized, placebo‐controlled trial at a tertiary hospital in southern China. Cesarean‐born infants were randomly assigned in a 1:1 ratio to receive maternal vaginal fluid (VMT group) or sterile saline‐soaked gauze (Con group) immediately after delivery. Vaginally delivered mother–infant dyads served as a natural reference group (VD group). The primary endpoint of the original trial was infant neurodevelopment at 6 months. In this follow‐up, social–emotion and neurodevelopment at 12 months were assessed using the Ages and Stages Questionnaires: Social–Emotional, Second Edition (ASQ:SE‐2) and Third Edition (ASQ‐3). Lower ASQ:SE‐2 scores indicate better social–emotion skills, while higher ASQ‐3 scores indicate better neurodevelopmental performance. This trial was registered with the Chinese Clinical Trial Registry, ChiCTR2000031326. Results A total of 210 mother–infant dyads were enrolled (VMT, Con, VD: n = 70 each) from December 10, 2020, to November 11, 2022. Infants in the VMT group had significantly lower ASQ:SE‐2 total scores than those in the Con group (31.01% decrease; mean difference [MD]: −9.24; 95% confidence interval [95% CI]: −16.04 to −2.45), with improvements in self‐regulation, social communication, and interaction with people. The VMT group also had higher ASQ‐3 scores in the personal–social subdomain (MD: 4.65; 95% CI: 0.15 to 9.15), but no significant difference in total ASQ‐3 scores (MD: 8.90; 95% CI, −2.9 to 20.70). No significant differences were found between the VMT and VD groups. The VMT group had a lower prevalence of social–emotional risk (adjusted RR: 0.39 [95% CI, 0.19 to 0.80]) than the Con group. Conclusions This pilot randomized clinical trial suggests that VMT may be associated with improved social–emotional development at 12 months in cesarean‐born infants, although the neurodevelopmental benefits observed earlier appear to diminish over time. Given the small sample size and exploratory nature, the findings should be interpreted with caution. Larger, multi‐center randomized controlled trials with longer follow‐up are needed to confirm these results and further evaluate the VMT's effectiveness.

Znalosti, které odpovídají vaší práci.

Od bezplatného začátku přes osobní rešerše literatury až po kompletní Research Suite.

Zobrazit tarify →

Jsou zahrnuty všechny plné texty vydavatelů?

Ne. Bibliografické záznamy, abstrakty a plné texty jsou různé typy obsahu. To, zda je plný text dostupný, závisí na zdroji, Open Access a vašich stávajících licencích. Tarif EUVIMED nenahrazuje dodatečná vydavatelská práva.

Zobrazit tarify →